NeoGeneStar LLC
www.neogenestar.comNeoGeneStar – Executive Summary NeoGeneStar has a patent pending method for the purification of cell-free DNA. The method directly addresses the market need for simplicity, cost-effectiveness, and reliability. Cell-free DNA can be used for Non-Invasive Prenatal Tests, ie. Testing an unborn baby by analyzing a blood sample from the mother’s arm. Cell-free DNA has also been shown to be extremely useful in cancer diagnostics and therapy.
Read moreNeoGeneStar – Executive Summary NeoGeneStar has a patent pending method for the purification of cell-free DNA. The method directly addresses the market need for simplicity, cost-effectiveness, and reliability. Cell-free DNA can be used for Non-Invasive Prenatal Tests, ie. Testing an unborn baby by analyzing a blood sample from the mother’s arm. Cell-free DNA has also been shown to be extremely useful in cancer diagnostics and therapy.
Read moreCountry
State
New Jersey
City (Headquarters)
Somerset
Industry
Employees
11-50
Founded
2014
Estimated Revenue
$1 to $1,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Chief Executive Officer
Email ****** @****.comPhone (***) ****-****
Technologies
(8)